ALKERMES | Rentekostnader



Interest Expense On Debt Endring Dato
AbbVie USD 610M 19M 2024-12
Acadia Pharmaceuticals 0 4.12M 2024-09
ALKERMES USD 0 4.65M 2025-03
Amgen USD 723M 24M 2025-03
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Bristol-Myers Squibb USD 494M 2M 2025-03
Eli Lilly USD 243.7M 19M 2025-03
Gilead Sciences USD 260M 12M 2025-03
Ionis Pharmaceuticals USD 19M 16.41M 2025-03
J&J USD 128M 9M 2025-03
Merck USD 313M 15M 2025-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Otsuka Holdings 13.74B 8.99B 2025-03
Pfizer USD 654M 85M 2025-03
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



ALKERMES Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.